The effects and mechanisms of isoliquiritigenin loaded nanoliposomes regulated AMPK/mTOR mediated glycolysis in colorectal cancer

References

• Song LL, Li YM. Current noninvasive tests for colorectal cancer screening: an overview of colorectal cancer screening tests. World J Gastrointest Oncol. 2016;8(11):793–800.
   PubMed Web of Science ®Google Scholar
• Siegel R. Cancer statistics. CA Cancer J Clin. 2013;63(1):277.
   Web of Science ®Google Scholar
• Anemone A, Consolino L, Conti L, et al. In vivo evaluation of tumour acidosis for assessing the early metabolic response and onset of resistance to dichloroacetate by using magnetic resonance pH imaging. Int J Oncol. 2017;51(2):498–506.
   PubMed Web of Science ®Google Scholar
• Zhao M, Liu Q, Gong Y, et al. GSH-dependent antioxidant defense contributes to the acclimation of colon cancer cells to acidic microenvironment. Cell Cycle. 2016;15(8):1125–1133.
   PubMed Web of Science ®Google Scholar
• Nam SO, Yotsumoto F, Miyata K, et al. Warburg effect regulated by amphiregulin in the development of colorectal cancer. Cancer Med. 2015;4(4):575–587.
   PubMed Web of Science ®Google Scholar
• Yan G, Li L, Bo Z, et al. Lipidome in colorectal cancer. Oncotarget. 2016;7(22):33429–33439.
   PubMedGoogle Scholar
• Vargas T, Moreno-Rubio J, Herranz J, et al. 3′UTR polymorphism in ACSL1 gene correlates with expression levels and poor clinical outcome in colon cancer patients. PLoS One. 2016;11(12):e0168423.
   PubMed Web of Science ®Google Scholar
• Zhang MH, Fang XS, Guo JY, et al. Effects of AMPK on apoptosis and energy metabolism of gastric smooth muscle cells in rats with diabetic gastroparesis. Cell Biochem Biophys. 2019;77(2):165–177.
   PubMed Web of Science ®Google Scholar
• Hardie DG, Schaffer BE, Brunet A. AMPK: an energy-sensing pathway with multiple inputs and outputs. Trends Cell Biol. 2016;26(3):190–201.
   PubMed Web of Science ®Google Scholar
• Hu M, Chen X, Ma L, et al. AMPK inhibition suppresses the malignant phenotype of pancreatic cancer cells in part by attenuating aerobic glycolysis. J Cancer. 2019;10(8):1870–1878.
   PubMed Web of Science ®Google Scholar
• Xiao Z, Liu S, Ai F, et al. SDHB downregulation facilitates the proliferation and invasion of colorectal cancer through AMPK functions excluding those involved in the modulation of aerobic glycolysis. Exp Ther Med. 2018;15(1):864–872.
   PubMed Web of Science ®Google Scholar
• Zhan P, Zhao S, Yan H, et al. α-Enolase promotes tumorigenesis and metastasis via regulating AMPK/mTOR pathway in colorectal cancer. Mol Carcinog. 2017;56(5):1427–1437.
   PubMed Web of Science ®Google Scholar
• Peng Y, Li X, Wu M, et al. New prognosis biomarkers identified by dynamic proteomic analysis of colorectal cancer. Mol Biosyst. 2012;8(11):3077–3088.
   PubMedGoogle Scholar
• Long NP, Lee WJ, Huy NT, et al. Novel biomarker candidates for colorectal cancer metastasis: a meta-analysis of in vitro studies. Cancer Inform. 2016;15(Suppl. 4):11–17.
   PubMedGoogle Scholar
• Wang G, Wang YZ, Yu Y, et al. Triterpenoids extracted from Rhus chinensis Mill Act against colorectal cancer by inhibiting enzymes in glycolysis and glutaminolysis: network analysis and experimental validation. Nutr Cancer. 2019;72:1–27.
   PubMed Web of Science ®Google Scholar
• Dai L, Pan G, Liu X, et al. High expression of ALDOA and DDX5 are associated with poor prognosis in human colorectal cancer. Cancer Manag Res. 2018;10:1799–1806.
   PubMed Web of Science ®Google Scholar
• Martins SF, Amorim R, Viana-Pereira M, et al. Significance of glycolytic metabolism-related protein expression in colorectal cancer, lymph node and hepatic metastasis. BMC Cancer. 2016;16:535.
   PubMed Web of Science ®Google Scholar
• Li Y, Zhao H, Wang Y, et al. Isoliquiritigenin induces growth inhibition and apoptosis through downregulating arachidonic acid metabolic network and the deactivation of PI3K/Akt in human breast cancer. Toxicol Appl Pharmacol. 2013;272(1):37–48.
   PubMed Web of Science ®Google Scholar
• Wu S, Xue J, Yang Y, et al. Isoliquiritigenin inhibits interferon-γ-inducible genes expression in hepatocytes through down-regulating activation of JAK1/STAT1, IRF3/MyD88, ERK/MAPK, JNK/MAPK and PI3K/Akt signaling pathways. Cell Physiol Biochem. 2015;37(2):501–514.
   PubMedGoogle Scholar
• Zhang X, Zhu P, Zhang X, et al. Natural antioxidant-isoliquiritigenin ameliorates contractile dysfunction of hypoxic cardiomyocytes via AMPK signaling pathway mediators. Mediators Inflamm. 2013;2013:390890.
   PubMed Web of Science ®Google Scholar
• Yamamoto S, Aizu E, Jiang H, et al. The potent anti-tumor-promoting agent isoliquiritigenin. Carcinogenesis. 1991;12(2):317–323.
   PubMed Web of Science ®Google Scholar
• Liu J, Wang Q, Adu-Frimpong M, et al. Preparation, in vitro and in vivo evaluation of isoliquiritigenin-loaded TPGS modified proliposomes. Int J Pharm. 2019;563:53–62.
   PubMed Web of Science ®Google Scholar
• Gang W, Jie WJ, Ping ZL, et al. Liposomal quercetin: evaluating drug delivery in vitro and biodistribution in vivo. Expert Opin Drug Deliv. 2012;9(6):599–613.
   PubMed Web of Science ®Google Scholar
• Wang G, Wang J, Wu W, et al. Advances in lipid-based drug delivery: enhancing efficiency for hydrophobic drugs. Expert Opin Drug Deliv. 2015;12(9):1475–1499.
   PubMed Web of Science ®Google Scholar
• Tan B, Xiao H, Li F, et al. The profiles of mitochondrial respiration and glycolysis using extracellular flux analysis in porcine enterocyte IPEC-J2. Anim Nutr. 2015;1(3):239–243.
   PubMedGoogle Scholar
• Qin Y, Cheng C, Lu H, et al. miR-4458 suppresses glycolysis and lactate production by directly targeting hexokinase2 in colon cancer cells. Biochem Biophys Res Commun. 2016;469(1):37–43.
   PubMed Web of Science ®Google Scholar
• Le DT, Jung S, Quynh NTN, et al. Inhibitory role of AMP-activated protein kinase in necroptosis of HCT116 colon cancer cells with p53 null mutation under nutrient starvation. Int J Oncol. 2019;54(2):702–712.
   PubMed Web of Science ®Google Scholar
• Shan M, Dai D, Vudem A, et al. Multi-scale computational study of the Warburg effect, reverse Warburg effect and glutamine addiction in solid tumors. PLoS Comput Biol. 2018;14(12):e1006584.
   PubMed Web of Science ®Google Scholar
• Hsu PP, Sabatini DM. Cancer cell metabolism: Warburg and beyond. Cell. 2008;134(5):703–707.
   PubMed Web of Science ®Google Scholar
• Satoh K, Yachida S, Sugimoto M, et al. Global metabolic reprogramming of colorectal cancer occurs at adenoma stage and is induced by MYC. Proc Natl Acad Sci USA. 2017;114(37):E7697–E7706.
   PubMed Web of Science ®Google Scholar
• Cairns RA, Harris IS, Mak TW. Regulation of cancer cell metabolism. Nat Rev Cancer. 2011;11(2):85–95.
   PubMed Web of Science ®Google Scholar
• Markert EK, Levine AJ, Vazquez A. Proliferation and tissue remodeling in cancer: the hallmarks revisited. Cell Death Dis. 2012;3:e397.
   PubMed Web of Science ®Google Scholar
• Rabinovitch RC, Samborska B, Faubert B, et al. AMPK maintains cellular metabolic homeostasis through regulation of mitochondrial reactive oxygen species. Cell Rep. 2017;21(1):1–9.
   PubMed Web of Science ®Google Scholar
• Raina K, Agarwal C, Wadhwa R, et al. Energy deprivation by silibinin in colorectal cancer cells: a double-edged sword targeting both apoptotic and autophagic machineries. Autophagy. 2013;9(5):697–713.
   PubMed Web of Science ®Google Scholar
• Qiu SL, Xiao ZC, Piao CM, et al. AMP-activated protein kinase α2 protects against liver injury from metastasized tumors via reduced glucose deprivation-induced oxidative stress. J Biol Chem. 2014;289(13):9449–9459.
   PubMed Web of Science ®Google Scholar
• Kanazawa M, Satomi Y, Mizutani Y, et al. Isoliquiritigenin inhibits the growth of prostate cancer. Eur Urol. 2003;43(5):580–586.
   PubMed Web of Science ®Google Scholar
• Ma J, Fu NY, Pang DB, et al. Apoptosis induced by isoliquiritigenin in human gastric cancer MGC-803 cells. Planta Med. 2001;67(8):754–757.
   PubMed Web of Science ®Google Scholar
• Hsu YL, Kuo PL, Lin LT, et al. Isoliquiritigenin inhibits cell proliferation and induces apoptosis in human hepatoma cells. Planta Med. 2005;71(2):130–134.
   PubMed Web of Science ®Google Scholar
• Wang KL, Hsia SM, Chan CJ, et al. Inhibitory effects of isoliquiritigenin on the migration and invasion of human breast cancer cells. Expert Opin Ther Targets. 2013;17(4):337–349.
   PubMed Web of Science ®Google Scholar
• Wang Z, Wang N, Han S, et al. Dietary compound isoliquiritigenin inhibits breast cancer neoangiogenesis via VEGF/VEGFR-2 signaling pathway. PLoS One. 2013;8(7):e68566.
   PubMed Web of Science ®Google Scholar
• Wang JR, Luo YH, Piao XJ, et al. Mechanisms underlying isoliquiritigenin-induced apoptosis and cell cycle arrest via ROS-mediated MAPK/STAT3/NF-κB pathways in human hepatocellular carcinoma cells. Drug Dev Res. 2019;80(4):461–470.
   PubMed Web of Science ®Google Scholar
• El Halabi I, Bejjany R, Nasr R, et al. Ascorbic acid in colon cancer: from the basic to the clinical applications. Int J Mol Sci. 2018;19(9):2752.
   PubMed Web of Science ®Google Scholar
• Wang G, Wang JJ, Yin PH, et al. Strategies to target energy metabolism in consensus molecular subtype 3 along with Kirsten rat sarcoma viral oncogene homolog mutations for colorectal cancer therapy. J Cell Physiol. 2019;234(5):5601–5612.
   PubMed Web of Science ®Google Scholar
• Aguirre-Portolés C, Fernández LP, Ramírez de Molina A. Precision nutrition for targeting lipid metabolism in colorectal cancer. Nutrients. 2017;9(10):1076.
   PubMed Web of Science ®Google Scholar
• Yun J, Mullarky E, Lu C, Bosch KN, et al. Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH. Science. 2015;350(6266):1391–1396.
   PubMed Web of Science ®Google Scholar
• Mitov MI, Harris JW, Alstott MC, et al. Temperature induces significant changes in both glycolytic reserve and mitochondrial spare respiratory capacity in colorectal cancer cell lines. Exp Cell Res. 2017;354(2):112–121.
   PubMed Web of Science ®Google Scholar
• van Schaardenburgh M, Wohlwend M, Rognmo Ø, et al. Mitochondrial respiration after one session of calf raise exercise in patients with peripheral vascular disease and healthy older adults. PLoS One. 2016;11(10):e0165038.
   PubMed Web of Science ®Google Scholar
• Ha TK, Chi SG. CAV1/caveolin 1 enhances aerobic glycolysis in colon cancer cells via activation of SLC2A3/GLUT3 transcription. Autophagy. 2012;8(11):1684–1685.
   PubMed Web of Science ®Google Scholar
• Tong X, Zhao F, Mancuso A, et al. The glucose-responsive transcription factor ChREBP contributes to glucose-dependent anabolic synthesis and cell proliferation. Proc Natl Acad Sci USA. 2009;106(51):21660–21665.
   PubMed Web of Science ®Google Scholar
• Ha TK, Her NG, Lee MG, et al. Caveolin-1 increases aerobic glycolysis in colorectal cancers by stimulating HMGA1-mediated GLUT3 transcription. Cancer Res. 2012;72(16):4097–4109.
   PubMed Web of Science ®Google Scholar
• Deran M, Yang J, Shen CH, et al. Energy stress regulates Hippo-YAP signaling involving AMPK-mediated regulation of angiomotin-like 1 protein. Cell Rep. 2014;9(2):495–503.
   PubMed Web of Science ®Google Scholar
• Yao G, Zhang Y, Wang D, et al. GDM-induced macrosomia is reversed by Cav-1 via AMPK-mediated fatty acid transport and GLUT1-mediated glucose transport in placenta. PLoS One. 2017;12(1):e0170490.
   PubMed Web of Science ®Google Scholar
• Inoki K, Kim J, Guan KL. AMPK and mTOR in cellular energy homeostasis and drug targets. Annu Rev Pharmacol Toxicol. 2012;52(1):381–400.
   PubMed Web of Science ®Google Scholar
• Johnson SM, Gulhati P, Rampy BA, et al. Novel expression patterns of PI3K/Akt/mTOR signaling pathway components in colorectal cancer. J Am Coll Surg. 2010;210(5):767–778.
   PubMed Web of Science ®Google Scholar
• Faller WJ, Jackson TJ, Knight JRP, et al. mTORC1-mediated translational elongation limits intestinal tumour initiation and growth. Nature. 2015;517(7535):497–500.
   PubMed Web of Science ®Google Scholar
• Li YC, He SM, He ZX, et al. Plumbagin induces apoptotic and autophagic cell death through inhibition of the PI3K/Akt/mTOR pathway in human non-small cell lung cancer cells. Cancer Lett. 2014;344(2):239–259.
   PubMed Web of Science ®Google Scholar
• Ma XM, Blenis J. Molecular mechanisms of mTOR-mediated translational control. Nat Rev Mol Cell Biol. 2009;10(5):307–318.
   PubMed Web of Science ®Google Scholar
• Kim N, Jeong S, Jing K, et al. Docosahexaenoic acid induces cell death in human non-small cell lung cancer cells by repressing mTOR via AMPK activation and PI3K/Akt inhibition. Biomed Res Int. 2015;2015:239764.
   PubMed Web of Science ®Google Scholar
• Toda K, Kawada K, Iwamoto M, et al. Metabolic alterations caused by KRAS mutations in colorectal cancer contribute to cell adaptation to glutamine depletion by upregulation of asparagine synthetase. Neoplasia. 2016;18(11):654–665.
   PubMed Web of Science ®Google Scholar
• Csibi A, Lee G, Yoon SO, et al. The mTORC1/S6K1 pathway regulates glutamine metabolism through the eIF4B-dependent control of c-Myc translation. Curr Biol. 2014;24(19):2274–2280.
   PubMed Web of Science ®Google Scholar
• Inoki K, Zhu T, Guan KL. TSC2 mediates cellular energy response to control cell growth and survival. Cell. 2003;115(5):577–590.
   PubMed Web of Science ®Google Scholar
• Gwinn DM, Shackelford DB, Egan DF, et al. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell. 2008;30(2):214.
   PubMed Web of Science ®Google Scholar